Conmed/$CNMD
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Conmed
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.
Ticker
$CNMD
Sector
Primary listing
NYSE
Employees
3,900
Headquarters
Website
Conmed Metrics
BasicAdvanced
$1.5bn
26.78
$1.84
0.93
$0.20
1.62%
Price and volume
Market cap
$1.5bn
Beta
0.93
52-week high
$56.64
52-week low
$31.44
Average daily volume
742k
Dividend rate
$0.20
Financial strength
Current ratio
1.484
Quick ratio
0.608
Long term debt to equity
63.094
Total debt to equity
80.109
Dividend payout ratio (TTM)
21.91%
Interest coverage (TTM)
5.12%
Profitability
EBITDA (TTM)
227.461
Gross margin (TTM)
55.58%
Net profit margin (TTM)
4.12%
Operating margin (TTM)
11.18%
Effective tax rate (TTM)
32.12%
Revenue per employee (TTM)
$350,000
Management effectiveness
Return on assets (TTM)
4.14%
Return on equity (TTM)
5.53%
Valuation
Price to earnings (TTM)
26.779
Price to revenue (TTM)
1.103
Price to book
1.42
Price to tangible book (TTM)
-4.62
Price to free cash flow (TTM)
11.251
Free cash flow yield (TTM)
8.89%
Free cash flow per share (TTM)
4.382
Dividend yield (TTM)
0.41%
Forward dividend yield
1.62%
Growth
Revenue change (TTM)
3.42%
Earnings per share change (TTM)
-48.00%
3-year revenue growth (CAGR)
6.39%
10-year revenue growth (CAGR)
6.44%
3-year earnings per share growth (CAGR)
-13.54%
10-year earnings per share growth (CAGR)
11.51%
3-year dividend per share growth (CAGR)
-37.00%
10-year dividend per share growth (CAGR)
-12.94%
What the Analysts think about Conmed
Analyst ratings (Buy, Hold, Sell) for Conmed stock.
Conmed Financial Performance
Revenues and expenses
Conmed Earnings Performance
Company profitability
Conmed News
AllArticlesVideos
CONMED Q2 Earnings Call Highlights
MarketBeat·1 week ago
CONMED Corporation Announces Expanded Indication for the FDA Cleared AirSeal® Robotic Solution for Use with the Intuitive da Vinci 5 Hex Cannula
Business Wire·2 weeks ago
CONMED Corporation to Report Second Quarter 2026 Financial Results on July 29, 2026
Business Wire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.